Clinical Trials Browser

Phase 2 × INDUSTRY × relugolix × Clear all

NCT04523207 2025-04-25

A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases

Phase 2 Completed

108 enrolled 13 charts

Prostatic Neoplasms

NCT02135445 2017-04-13

Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer

Phase 2 Completed

103 enrolled 42 charts

Prostatic Neoplasms

NCT01452659 2013-01-21

Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids

Phase 2 Completed

Leiomyoma